Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Interim Management Statement January 2008

Abstract:
Oxford Instruments plc, the high technology tools and systems company, issues today an Interim Management Statement which covers the period from 1 October 2007 to 14 January 2008, as required by the UK Listing Authority's Disclosure and Transparency Rules.

Interim Management Statement January 2008

UK | Posted on January 14th, 2008

Our core environmental and nanotechnology markets remain robust despite market concerns over global economic conditions. Our Research and Development programme continues to convert our technological capabilities into innovative new products, meeting the needs of our customers. This combination of robust markets and commercially orientated innovation has helped to ensure that our organic growth plans remain on track. Furthermore, the integration of our two recent acquisitions, Vericold and WAS, is proceeding to plan with strong trading results to date from both companies.


Save as described in this statement, there has been no significant change in the financial position of the Group in the period. The Board continues to be confident that the Group's full year performance will meet expectations.

####

About Oxford Instruments plc
Oxford Instruments specialises in the design, manufacture and support of high-technology tools and systems for industry, research, education, space, energy, defence and healthcare.

We combine core technologies in areas such as low temperature and high magnetic field environments; X-ray, electron and optical based metrology; nuclear magnetic resonance, advanced growth, deposition and etching.

Our aim is to be the leading provider of tools and systems for the emerging nanotechnology and bioscience markets.

For more information, please click here

Contacts:
Jonathan Flint
Chief Executive

Enquiries:

Oxford Instruments plc Tel: 01865 393200
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director

Hogarth Partnership Limited Tel: 020 7357 9477
Rachel Hirst / Andrew Jaques / Ian Payne

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New method in the fight against forever chemicals September 13th, 2024

Energy transmission in quantum field theory requires information September 13th, 2024

Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Announcements

Giving batteries a longer life with the Advanced Photon Source: New research uncovers a hydrogen-centered mechanism that triggers degradation in the lithium-ion batteries that power electric vehicles September 13th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

New method in the fight against forever chemicals September 13th, 2024

Tools

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024

New microscope offers faster, high-resolution brain imaging: Enhanced two-photon microscopy method could reveal insights into neural dynamics and neurological diseases August 16th, 2024

Atomic force microscopy in 3D July 5th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project